1. Home
  2. WVE vs ATEC Comparison

WVE vs ATEC Comparison

Compare WVE & ATEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

HOLD

Current Price

$15.74

Market Cap

3.2B

Sector

Health Care

ML Signal

HOLD

Logo Alphatec Holdings Inc.

ATEC

Alphatec Holdings Inc.

HOLD

Current Price

$20.68

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WVE
ATEC
Founded
2012
1990
Country
Singapore
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
3.1B
IPO Year
2015
2006

Fundamental Metrics

Financial Performance
Metric
WVE
ATEC
Price
$15.74
$20.68
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
16
11
Target Price
$29.94
$22.00
AVG Volume (30 Days)
13.7M
1.9M
Earning Date
11-10-2025
10-30-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$109,230,000.00
$728,020,000.00
Revenue This Year
N/A
$26.81
Revenue Next Year
$16.00
$16.66
P/E Ratio
N/A
N/A
Revenue Growth
103.75
27.11
52 Week Low
$5.28
$8.81
52 Week High
$21.73
$22.66

Technical Indicators

Market Signals
Indicator
WVE
ATEC
Relative Strength Index (RSI) 55.08 53.91
Support Level $15.23 $20.84
Resistance Level $18.50 $21.30
Average True Range (ATR) 1.18 0.57
MACD -0.34 -0.02
Stochastic Oscillator 16.51 69.54

Price Performance

Historical Comparison
WVE
ATEC

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About ATEC Alphatec Holdings Inc.

Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others.

Share on Social Networks: